Hester Biosciences Ltd share price logo

Hester Biosciences Share Price

NSE: HESTERBIO

BSE: 524669

Small Cap

Healthcare Sector

₹1559.60

-5.00

(-0.32%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Tech Chart

Hester Biosciences Stock Performance

as on February 16, 2026 at 3:27 pm IST

  • Day's Low

    Day's High

    ₹1,558.70
    ₹1,629.00
    downward going graph

    0.06%

    Downside

    4.45%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    ₹1,242.95
    ₹2,350.00
    downward going graph

    20.30%

    Downside

    50.68%

    Upside

    downward going graph

Hester Biosciences share price movements today

Previous Close
₹1,564.60
Open
₹1,559.30
Volume
993.00
Upper Circuit
₹1,877.50
Lower Circuit
₹1,251.70
Day's Low - High
₹1,558.70 - ₹1,629.00
52 Week Low - High
₹1,242.95 - ₹2,350.00

Hester Biosciences Historical Returns

1 Month Return
+ 3.6 %
3 Month Return
-6.08 %
1 Year Return
-4.16 %
3 Year Return
-13.25 %
5 Year Return
-9.52 %

Hester Biosciences Fundamentals

as on February 16, 2026 at 9:57 am IST

Market Cap

₹1,330.98 Cr

Return on Equity (ROE)

9.77

PE Ratio (TTM)

31.33

Return on capital employed (ROCE)

9.47

Industry PE ratio

41.52

Beta (LTM)

0.74

P/B Ratio

3.15

Dividend Yield

0.56

PEG Ratio

3.03

Quarterly Earnings Growth YOY

-18.4

EPS (TTM)

33.89

Sector

Pharmaceuticals

Book Value

369.41

Technical Analysis

Bullish

View Technical Analysis

Hester Biosciences Stock Valuation

as on February 16, 2026 at 9:57 am IST

Hester Biosciences in the last 5 years

  • Overview

  • Trends

Lowest (19.52x)

March 23, 2020

Today (31.33x)

February 13, 2026

Industry (41.52x)

February 13, 2026

Highest (124.52x)

July 26, 2024

LowHigh

Today’s Price to Earnings Ratio: 31.33x

Hester Biosciences Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Hester Biosciences with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
Hester Biosciences Ltd image
Hester Biosciences Ltd
NA1,330.98-1.9%0.7428311
Curis Lifesciences Ltd image
Curis Lifesciences Ltd
NA84.08-5.25%0.00649
Chandra Bhagat Pharma Ltd image
Chandra Bhagat Pharma Ltd
NA31.840.1%0.00186
Vasundhara Rasayans Ltd image
Vasundhara Rasayans Ltd
NA43.1415.91%0.00433
Kimia Biosciences Ltd image
Kimia Biosciences Ltd
NA189.01-0.93%0.009118
See all

Hester Biosciences Share Price Target

Get share price movements and forecasts by analysts on Hester Biosciences.

Source: S&P Global Market Intelligence

Hester Biosciences Stock’s Investor Sentiment and Interest

Search interest for Hester Biosciences Ltd Stock has increased by 32% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:32% versus previous 30 day period

Hester Biosciences Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Sales
67.3
87.85
70.46
66.98
79.26
82.27
83.69
63.22
81.93
84.11
70.97
77.42
Other Income
3.49
2.52
5.91
2.2
4.63
2.09
2.8
8.78
-5.64
3.37
11.88
1.98
Total Income
70.78
90.37
76.36
69.18
83.88
84.35
86.49
72
76.29
87.47
82.85
79.4
Expenses
55.62
73.49
57.24
56.83
63.33
64.62
64.53
58.16
62.74
61.29
59.25
59.62
Operating Profit
11.68
14.36
13.22
10.15
15.93
17.65
19.16
5.06
19.19
22.82
11.72
17.8
Operating Profit Margin %
17.36%
16.35%
18.76%
15.15%
20.1%
21.45%
22.89%
8%
23.42%
27.13%
16.51%
22.99%
Profit Before Interest, Tax and Depreciation
15.16
16.88
19.12
12.35
20.55
19.74
21.96
13.85
13.54
26.18
23.6
19.78
Interest
1.37
2.57
8.08
2.19
6.94
5.01
5.89
-3.81
5.62
1.81
2.21
1.82
Depreciation
5.37
5.4
4.28
3.75
3.74
4.13
4.2
4.29
4.18
4.18
4.35
4.43
Profit Before Tax
8.42
8.91
6.76
6.41
9.87
10.6
11.87
13.37
3.74
20.19
17.04
13.53
Tax Paid
2.71
2.2
2.72
2.4
3.47
3.11
3.48
1.96
2.2
2.9
2.71
4.22
Profit After Tax
5.71
6.71
4.04
4.02
6.4
7.49
8.39
11.41
1.54
17.3
14.33
9.31
Total Net profit including share of profit / Loss from associate company
5.71
6.71
4.04
4.02
6.4
7.49
8.39
11.41
1.54
17.3
14.33
9.31
EPS
6.72
7.89
4.75
4.73
7.52
8.8
9.86
13.41
1.82
20.33
16.85
10.94
Actual EPS
6.72
7.89
4.75
4.73
7.52
8.8
9.86
13.41
1.82
20.33
16.85
10.94
Adjusted EPS
6.72
7.89
4.75
4.73
7.52
8.8
9.86
13.41
1.82
20.33
16.85
10.94
Diluted EPS
6.72
7.89
4.75
4.73
7.52
8.8
9.86
13.41
1.82
20.33
16.85
10.94

Hester Biosciences Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Sales
121.02
132.6
178.07
183.27
214.33
235.01
266.09
304.55
311.1
Other Income
0.42
2.55
7.21
6.37
4.68
14.16
19.56
15.25
8.02
Total Income
123.53
138.49
185.28
189.63
219.02
249.17
285.65
319.79
319.13
Expenses
82.09
88.68
110.03
127.87
149
175.02
215.48
250.89
250.05
Operating Profit
38.93
43.92
68.04
55.4
65.33
59.99
50.61
53.66
61.05
Operating Profit Margin %
32.17%
33.12%
38.21%
30.23%
30.48%
25.53%
19.02%
17.62%
19.62%
Profit Before Interest, Tax and Depreciation
41.44
49.82
75.25
61.77
70.02
74.15
70.17
68.9
69.08
Interest
3.5
4.04
6.63
7.37
6.6
4.06
9.32
19.78
12.7
Depreciation
7
9.66
11.76
13.07
13.31
16.58
20.7
17.17
16.8
Profit Before Tax
30.94
36.12
56.86
41.33
50.11
53.51
40.15
31.95
39.58
Tax Paid
8.14
13.06
16.16
10.33
15.41
14.01
12.12
10.79
10.74
Profit After Tax
22.79
23.07
40.69
31
34.7
39.48
28.04
21.17
28.83
Total Net profit including share of profit / Loss from associate company
22.79
23.07
40.69
31
34.7
39.48
28.04
21.17
28.83
EPS
26.79
27.12
47.84
36.44
40.79
46.41
32.96
24.88
33.89
Actual EPS
26.79
27.12
47.84
36.44
40.79
46.41
32.96
24.88
33.89
Adjusted EPS
26.79
27.12
47.84
36.44
40.79
46.41
32.96
24.88
33.89
Diluted EPS
26.79
27.12
47.84
36.44
40.79
46.41
32.96
24.88
33.89

Hester Biosciences Ltd Cash Flow

Figures in Rupees Crores

Mar 2016
Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Net Cash from Operating Activities
18.85
34.8
38.02
46.71
36.77
58.05
8.71
23.6
48.18
64.51
Cash Flow from Investing Activities
0.59
0.06
-2.82
1.61
0.86
-1.35
-21.07
0.82
1.95
1.08
Cash Flow from Financing Activities
-6.69
1.83
-11.08
2.64
18.74
-18.23
111.55
41.75
-26.1
-51.72
Net Cash Flow
-1.14
6.45
1.15
28.32
-17.12
-2.26
3.48
-11.59
-0.36
-6.72

Hester Biosciences Stock Shareholding Pattern

Numbers in percentages

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Promoters
53.73%
53.73%
53.73%
53.73%
53.73%
53.73%
53.73%
53.73%
53.73%
53.73%
53.73%
53.73%
DII
0%
0%
0%
0%
0%
0%
0.02%
0.02%
0.02%
0.02%
0%
0.01%
FII
0%
0%
0%
0%
0.43%
0.52%
0.61%
0.59%
0.87%
0.52%
0.53%
0.51%
Public
45.82%
45.82%
45.85%
45.84%
45.84%
45.74%
45.64%
45.65%
45.38%
45.73%
45.74%
45.75%
Total Outstanding Shares
85,06,865
85,06,865
85,06,865
85,06,865
85,06,865
85,06,865
85,06,865
85,06,865
85,06,865
85,06,865
85,06,865
85,06,865
Total Shareholders
13,120
12,984
13,342
13,450
12,844
11,305
11,538
11,473
11,853
11,810
12,260
12,603

Mutual Funds that own Hester Biosciences Stock

Check out the Mutual Funds with significant holdings in Hester Biosciences.

Hester Biosciences Corporate Actions

View detailed summary of the earnings and dividend history of Hester Biosciences.

  • Hester Biosciences Ltd Earnings Results

    Hester Biosciences Ltd’s net profit fell -24.79% since last year same period to ₹8.77Cr in the Q3 2025-2026. On a quarterly growth basis, Hester Biosciences Ltd has generated -39.31% fall in its net profits since last 3-months.

    Read More about Earnings Results

  • Hester Biosciences Ltd Dividends May,2025

    In the quarter ending March 2025, Hester Biosciences Ltd has declared dividend of ₹7.00 per share on 09 May 2025 - translating a dividend yield of 0.83%.

    Read More about Dividends

Indices Featuring Hester Biosciences Stock

Check stock indices that include Hester Biosciences.

BSE Healthcare

₹42,847.82

0.49 (▲210.87%)

Insights on Hester Biosciences Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, HESTERBIO stock has moved up by 3.1%

  • imgPOSITIVE IMPACT

    Retail Holding Up

    img

    Retail Investor have increased holdings from 45.74% to 45.75% in Dec 2025 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Torrent Pharmaceuticals Ltd has given 32.5% return, outperforming this stock by 36.6%

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 53.73% of holdings in Dec 2025 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Torrent Pharmaceuticals Ltd has given 169.7% return, outperforming this stock by 182.4%

  • imgNEGATIVE IMPACT

    FII Holding Down

    img

    Foreign Institutions have decreased holdings from 0.53% to 0.51% in Dec 2025 quarter

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 3 quarters, 16.44 Cr → 8.77 Cr (in ₹), with an average decrease of 25.7% per quarter

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 3 quarters, 87.47 Cr → 79.4 Cr (in ₹), with an average decrease of 4.7% per quarter

About Hester Biosciences Ltd

Hester Pharmaceutical (HPL), established as a private limited company in April 1987 and transitioning to a public limited company in November of 1993, offers a range of veterinary and pharmaceutical products, such as animal health products, poultry vaccines, and laboratory kits and reagents. Furthermore, it markets the veterinary products of up to 10 international companies, including Ghen Corporation (Japan), Maine Biological Laboratories (US), Idexx Corporation (US), and Biogal Galed Laboratories (Israel). Entering the production of veterinary vaccines in vials, HPL also has technical collaborations with Maine Biological Laboratories and Ghen Corporation, and has since received licenses for producing an additional 10 poultry vaccines. To facilitate increased production, HPL has signed a manufacturing agreement with Sinsui Inc. for the production of additional poultry vaccines. Overall, HPL has continued to grow in the years since it was first established.

Revenue: ₹77.42Cr as on December 2025 (Q3 FY26)
Net Profit: ₹9.31Cr as on December 2025 (Q3 FY26)
Listing date: 13 Mar, 2015
OrganisationHester Biosciences Ltd
IndustryPharmaceuticals
E-voting on sharesClick here to vote

FAQs

What is Hester Biosciences share price today?

Hester Biosciences share price today stands at ₹1559.6 as on . Hester Biosciences share today touched a day high of ₹1629 and a low of ₹1558.7.

What is the 52 week high and 52 week low range for Hester Biosciences share?

Hester Biosciences touched a 52 week high of ₹2350 and a 52 week low of ₹1242.95. Hester Biosciences share price today i.e. is trending at ₹1559.6, which is -33.63% down from its 52 week high and 25.48% up from its 52 week low.

What is Hester Biosciences's market capitalisation today?

Hester Biosciences market capitalisation is ₹1,330.98 Cr as on .

How to buy Hester Biosciences shares?

To buy Hester Biosciences shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for HESTERBIO or Hester Biosciences Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Hester Biosciences shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Hester Biosciences trading volume today?

Hester Biosciences trading volume is 993.00 as on . This means that 993.00 shares of Hester Biosciences were bought and sold on the stock market during today's trading session.